A phase 1, first-in-human clinical trial of DS-1211 in healthy volunteers

Trial Profile

A phase 1, first-in-human clinical trial of DS-1211 in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs DS-1211 (Primary)
  • Indications Calcinosis
  • Focus Adverse reactions; First in man
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 08 Sep 2017 New trial record
    • 06 Sep 2017 According to a Daiichi Sankyo Company media release, first subject has been enrolled in this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top